Contents
MaaT Pharma offers an approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. The company is committed to treating blood cancers and graft-versus-host disease.
Timeline
February 2020
MaaT Pharma raises a $21,500,000 series B round from Biocodex, Crédit Mutuel Innovation and Seventure Partners.
March 2016
MaaT Pharma raises a $12,000,000 series A round from Crédit Mutuel Innovation and Seventure Partners.
July 2015
MaaT Pharma raises a $1,200,000 seed round from Seventure Partners.
January 2015
MaaT Pharma raises a $1,200,000 seed round from Seventure Partners.
2014
MaaT Pharma was founded by Herve Affagard.
Funding Rounds
Open in Query Tool
Products
Open in Query Tool
Acquisitions
Open in Query Tool
SBIR/STTR Awards
Open in Query Tool
Patents
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
References
Company attributes
Industry
Location
B2X
CEO
Founder
Pitchbook URL
Date Incorporated
2014
Number of Employees (Ranges)
20 – 49
Full Address
317 Avenue Jean Jaurès 69007 Lyon France
70 Avenue Tony Garnier 69007 Lyon
Investors
Email Address
contact@maat-pharma.com
Phone Number
+33953413965
Total Funding Amount (USD)
35,900,000
Latest Funding Round Date
February 2020
Latest Funding Type
Other attributes
Company Operating Status
Active
Country
